Bris­tol-My­ers craters af­ter block­buster check­point drug Op­di­vo fails key lung can­cer study

Bris­tol-My­ers Squibb an­nounced this morn­ing that Op­di­vo has flopped in a late-stage study on non-small cell lung can­cer, pre­sent­ing a stun­ning set­back for the star …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER